Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) When to biopsy seminal vesicles
Journal Information
Vol. 39. Issue 4.
Pages 203-209 (May 2015)
Share
Share
Download PDF
More article options
Visits
138
Vol. 39. Issue 4.
Pages 203-209 (May 2015)
Original article
When to biopsy seminal vesicles
¿Cuándo biopsiar las vesículas seminales?
Visits
138
J. Panach-Navarrete
Corresponding author
jorpanav22@gmail.com

Corresponding author.
, F. García-Morata, J.A. Hernández-Medina, J.M. Martínez-Jabaloyas
Servicio de Urología, Hospital Clínico Universitario de Valencia, Valencia, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Description of the sample (n=466).
Table 2. Univariate analysis. Relationship between pre-biopsy quantitative variables and infiltration of seminal vesicles.
Table 3. Multiple logistic regression model for infiltrated seminals.
Show moreShow less
Abstract
Objectives

The involvement of seminal vesicles in prostate cancer can affect the prognosis and determine the treatment. The objective of this study was to determine whether we could predict its infiltration at the time of the prostate biopsy to know when to indicate the biopsy of the seminal vesicles.

Material and methods

Observational retrospective study of 466 patients who underwent seminal vesicle biopsy. The indication for this biopsy was a prostate-specific antigen (PSA) level greater than 10ng/ml or an asymmetric or obliterated prostatoseminal angle. The following variables were included in the analysis: PSA level, PSA density, prostate volume, number of cores biopsied, suspicious rectal examination, and preservation of the prostatoseminal angle, studying its relationship with the involvement of the seminal vesicles.

Results

Forty-one patients (8.8%) had infiltrated seminal vesicles and 425 (91.2%) had no involvement. In the univariate analysis, the cases with infiltration had a higher mean PSA level (P<.01) and PSA density (P<.01), as well as a lower mean prostate volume (P<.01). A suspicious rectal examination (20.7% of the infiltrated vesicles) and the obliteration or asymmetry of the prostatoseminal angle (33.3% of the infiltrated vesicles) were significantly related to the involvement (P<.01). In the multivariate analysis, we concluded that the probability of having infiltrated seminal vesicles is 5.19 times higher if the prostatoseminal angle is not preserved (P<.01), 4.65 times higher for PSA levels >19.60ng/dL (P<.01) and 2.95 times higher if there is a suspicious rectal examination (P=.014). Furthermore, this probability increases by 1.04 times for each unit of prostate volume lower (P<.01). The ROC curves showed maximum sensitivity and specificity at 19.6ng/mL for PSA and 0.39 for PSA density.

Conclusions

In this series, greater involvement of seminal vesicles was associated with a PSA level ≥20ng/ml, a suspicious rectal examination and a lack of prostatoseminal angle preservation.

Keywords:
Seminal vesicles
Biopsy
Prostate cancer
Resumen
Objetivos

La afectación de las vesículas seminales en el cáncer de próstata puede afectar al pronóstico y condicionar el tratamiento. El objetivo es conocer si podemos predecir su infiltración en el momento de realizar la biopsia prostática para saber cuándo hay que indicar la biopsia de las mismas.

Material y métodos

Estudio retrospectivo observacional sobre 466 pacientes a los que se les realizó biopsia de vesículas seminales. La indicación de esta biopsia fue: PSA mayor de 10ng/ml o ángulo prostatoseminal no conservado. En el análisis se incluyeron las siguientes variables: PSA, densidad de PSA, volumen prostático, número de cilindros biopsiados, tacto rectal sospechoso y conservación del ángulo prostatoseminal, estudiándose su relación con la afectación de las vesículas seminales.

Resultados

Cuarenta y un sujetos (8,8%) con vesículas seminales infiltradas y 425 (91,2%) libres de afectación. En el análisis univariado los casos con infiltración tenían una media superior en PSA (p<0,01) y densidad de PSA (p<0,01), además de una media de volumen prostático menor (p<0,01). El tacto rectal sospechoso (20,7% de las infiltradas) y la no conservación del ángulo prostatoseminal (33,3% de las infiltradas) se relacionaron de forma significativa con la afectación (p<0,01). En el análisis multivariado se concluye que la probabilidad de tener vesículas seminales infiltradas es 5,19 veces mayor si el ángulo prostatoseminal no está conservado (p<0,01), 4,65 veces mayor si el PSA>19,60ng/dl (p<0,01) y 2,95 veces mayor si existe tacto rectal sospechoso (p=0,014). Asimismo, aumenta en 1,04 veces por unidad de volumen menor (p<0,01). Las curvas ROC mostraron máxima sensibilidad y especificidad en 19,6ng/ml para PSA y 0,39 para densidad de PSA.

Conclusiones

En esta serie se asocian con mayor afectación de vesículas seminales un PSA mayor o igual a 20ng/ml, un tacto rectal sospechoso, o la ausencia de conservación del ángulo prostatoseminal.

Palabras clave:
Vesículas seminales
Biopsia
Cáncer de próstata

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos